Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
- F. F. Peres, M. C. Diana, M. A. Suiama, V. Justi, V. Abílio
- Medicine
- Schizophrenia Research
- 1 April 2016
Currently, the pharmacotherapy of schizophrenia is still associated with significant side effects and high rates of treatment resistance, causing a great deal of suffering to patients and their… Expand
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
- F. F. Peres, R. Levin, +11 authors V. Abílio
- Medicine
- Front. Pharmacol.
- 28 September 2016
Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory, and neuroprotective effects. In Parkinson’s disease patients, CBD… Expand
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
- F. F. Peres, M. C. Diana, +8 authors V. Abílio
- Medicine
- Front. Pharmacol.
- 21 August 2018
Schizophrenia is considered a debilitating neurodevelopmental psychiatric disorder and its pharmacotherapy remains problematic without recent major advances. The development of interventions able to… Expand
Peripubertal exposure to environmental enrichment prevents schizophrenia-like behaviors in the SHR strain animal model
- C. M. Santos, F. F. Peres, M. C. Diana, V. Justi, V. Abílio
- Psychology, Medicine
- Schizophrenia Research
- 1 October 2016
Schizophrenia is a highly disabling mental disorder, in which genetics and environmental factors interact culminating in the disease. The treatment of negative symptoms and cognitive deficits with… Expand
A schizophrenia-like behavioral trait in the SHR model: Applying confirmatory factor analysis as a new statistical tool
- F. F. Peres, R. Eufrásio, D. A. Gouvêa, M. C. Diana, H. Cogo-Moreira
- Psychology, Medicine
- Progress in Neuro-Psychopharmacology and…
- 13 July 2018
ABSTRACT Questionnaires that assess symptoms of schizophrenia patients undergo strict statistical validation, often using confirmatory factor analysis (CFA). CFA allows testing the existence of a… Expand
Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR)
- M. C. Diana, M. Santoro, G. Xavier, C. M. Santos, S. Belangero
- Medicine
- Psychiatry Research
- 30 October 2015
The Spontaneously Hypertensive Rat (SHR) strain is a classical animal model for the study of essential hypertension. Recently, our group suggested that this strain could be a useful animal model for… Expand
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia‐related behaviors in an animal model: The SHR strain
- M. C. Diana, F. F. Peres, +5 authors Vanesssa Costhek Abilio
- Medicine
- CNS neuroscience & therapeutics
- 1 July 2018
The treatment of schizophrenia with antipsychotics is still unsatisfactory. Therefore, the search for new treatments and prevention is crucial, and animal models are fundamental tools for this… Expand